Considering that obesity is associated with the development of insulin resistance and T2DM, but not all obese individuals become insulin resistant or diabetic, there is reason to believe serum and AT composition, or AT location, might differ in obese individuals with or without other metabolic alterations [18,23]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.